These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 2790605

  • 1. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ, Barr RD, Andrew M, deVeber LL, Pai MK.
    CMAJ; 1989 Oct 01; 141(7):693-7. PubMed ID: 2790605
    [Abstract] [Full Text] [Related]

  • 2. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan 01; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 01; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 4. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL.
    J Clin Oncol; 2003 Oct 01; 21(19):3616-22. PubMed ID: 14512392
    [Abstract] [Full Text] [Related]

  • 5. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
    Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE.
    N Engl J Med; 1986 Sep 11; 315(11):657-63. PubMed ID: 2943992
    [Abstract] [Full Text] [Related]

  • 6. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
    Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB.
    J Clin Oncol; 2007 Mar 01; 25(7):813-9. PubMed ID: 17327603
    [Abstract] [Full Text] [Related]

  • 7. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R, Derulska D, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Duczmal B, Jakowicka M.
    Acta Haematol Pol; 1992 Mar 01; 23(1):43-7. PubMed ID: 1615750
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep 01; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 10. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 01; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 11. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    Athale UH, Siciliano SA, Crowther M, Barr RD, Chan AK.
    Br J Haematol; 2005 Jun 01; 129(6):803-10. PubMed ID: 15953008
    [Abstract] [Full Text] [Related]

  • 12. Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
    Koizumi S, Fujimoto T, Sasaki K, Takeda T, Utsumi J, Mimaya J, Ohta S, Ninomiya T, Takaue Y.
    Int J Hematol; 1991 Aug 01; 54(4):307-13. PubMed ID: 1777605
    [Abstract] [Full Text] [Related]

  • 13. Acute lymphoblastic leukemia in infants.
    Gürgey A, Yetgin S, Cetin M, Gümrük F, Tuncer AM, Tunçbilek E, Hiçsönmez G.
    Turk J Pediatr; 2004 Aug 01; 46(2):115-9. PubMed ID: 15214738
    [Abstract] [Full Text] [Related]

  • 14. [The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Derulska D, Rokicka-Milewska R, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Darmal B, Jakowicka M.
    Acta Haematol Pol; 1991 Aug 01; 22(2):223-32. PubMed ID: 1841493
    [Abstract] [Full Text] [Related]

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 16. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.
    J Clin Oncol; 2003 Sep 01; 21(17):3262-8. PubMed ID: 12947061
    [Abstract] [Full Text] [Related]

  • 17. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA, Silverman LB, Schorin MA, Clavell LA, Dalton VK, Glick KM, Gelber RD, Sallan SE.
    Cancer; 2000 Apr 15; 88(8):1964-9. PubMed ID: 10760775
    [Abstract] [Full Text] [Related]

  • 18. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME, Children's Cancer Group.
    J Clin Oncol; 2003 Apr 15; 21(8):1612-7. PubMed ID: 12697887
    [Abstract] [Full Text] [Related]

  • 19. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.
    Med Pediatr Oncol; 2001 Jul 15; 37(1):10-9. PubMed ID: 11466717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.